当前位置: 首页 > 期刊 > 《中外健康文摘·医药月刊》 > 2008年第3期
编号:11608191
药物治疗肺纤维化的研究进展(2)
http://www.100md.com 2008年3月1日 《医药月刊》 2008年第3期
     [3] 张战民,李立,赵建军. 阿奇霉素对特发性肺间质纤维化干预作用的临床研究[J].中国综合临床,2005,21:1079-81.

    [4] Azuma A. Nukiwa T, Tsuboi E, et al. Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med, 2005, 171:1040-7.

    [5] 何平平,李健芝,张书杰,等. 阻断局部肾素-血管紧张素-醛固酮系统不同环节对大鼠肺间质纤维化肿瘤坏死因子α表达的影响[J].中国组织工程研究与临床康复,2007,11:4108-11.

    [6] Demedis MB, Convasce GC, Dekhuijzen R, et al. IFIGENIA:effects of N-acctylcuseine on primary end points VC and dico.Eru Respire J,2004,24:668S.

    [7] Yildirim Z, Kotuk M, Iraz M ,et al.Attenuation of bleomycin-induced lung fibrosis by oral sulfhydryl containing antioxidants in rats:erdosteien and N-acetylcysteine. Pulm Pharmacol Ther,2005,18:367-73.

    [8] Kubo H,Nakayama K,Yanai M,et al.Anticoagulant therapy for idiopathic pulmonary fibrosis. Chest,2005,128:1475-82.

    [9] Bonniaud P,Margetts PJ,Kolb M,et al.Progressive transforming growth growth factor{beta}-induced lung fibrosis is blocked by an orally active ALK5 kinase inhibitor.Am J Respir Crit Care Med,2005,171:889-98.

    [10]Raghu G,Brown KK,Bradford WZ,et al.A placebo- controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis.N Engl J Med,2004,350:125-33.

    [11]Karla S, Utz JP, Ryu JH,et al. Interferon gamma-1b therapy for advanced idiopathic pulmonary fibrosis. Mayo Clin Proc,2003,78:1082-7., http://www.100md.com(林轶静 喻昌利 王红阳 刘信荣 刘 晨)
上一页1 2